These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22782840)

  • 21. Improving survey methods in sero-epidemiological studies of injecting drug users: a case example of two cross sectional surveys in Serbia and Montenegro.
    Judd A; Rhodes T; Johnston LG; Platt L; Andjelkovic V; Simić D; Mugosa B; Simić M; Zerjav S; Parry RP; Parry JV
    BMC Infect Dis; 2009 Feb; 9():14. PubMed ID: 19203380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology of HIV/AIDS, hepatitis B, hepatitis C, and tuberculosis among minority injection drug users.
    Estrada AL
    Public Health Rep; 2002; 117 Suppl 1(Suppl 1):S126-34. PubMed ID: 12435836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.
    Loebstein R; Mahagna R; Maor Y; Kurnik D; Elbaz E; Halkin H; Olchovsky D; Ezra D; Almog S
    Isr Med Assoc J; 2008 Nov; 10(11):775-8. PubMed ID: 19070285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risks for HIV, HBV, and HCV infections among male injection drug users in northern Vietnam: a case-control study.
    Quan VM; Go VF; Nam le V; Bergenstrom A; Thuoc NP; Zenilman J; Latkin C; Celentano DD
    AIDS Care; 2009 Jan; 21(1):7-16. PubMed ID: 19085215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV and HCV prevalence and incarceration-related risks among injecting drug users in three West Bank governorates.
    Štulhofer A; Jwehan I; AbuRabie R
    AIDS Care; 2016 Sep; 28(9):1159-65. PubMed ID: 26936370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of HIV and other infections and injection behaviours among people who inject drugs in Addis Ababa, Ethiopia.
    Demissie M; Johnston LG; Muleta M; Desyebelew D; Belete W; G/Egxiabehre A; Gezahegn N; Kassa D; Aseffa Y
    Afr J AIDS Res; 2018 Sep; 17(3):259-264. PubMed ID: 30319040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A certain fate: spread of HIV among young injecting drug users in Manipur, north-east India.
    Eicher AD; Crofts N; Benjamin S; Deutschmann P; Rodger AJ
    AIDS Care; 2000 Aug; 12(4):497-504. PubMed ID: 11091782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Survey of prevalence of HIV infection, syphilis and HCV infection and related risk behaviors among club drug users in Zhejiang, 2011].
    Pan X; Jiang J; He H; Chen L; Yang J; Zhang H; Wang N
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Sep; 36(9):934-40. PubMed ID: 26814857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal.
    Neaigus A; Zhao M; Gyarmathy VA; Cisek L; Friedman SR; Baxter RC
    J Urban Health; 2008 May; 85(3):309-22. PubMed ID: 18340537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS; Brajachand N; Singh HL; Singh YM
    J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
    Maher L; Chant K; Jalaludin B; Sargent P
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV prevalence and risk behavior among injection drug users and their sex partners in two Russian cities.
    Eritsyan KU; Levina OS; White E; Smolskaya TT; Heimer R
    AIDS Res Hum Retroviruses; 2013 Apr; 29(4):687-90. PubMed ID: 23186172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HCV status knowledge and risk behaviours amongst intravenous drug users.
    Vidal-Trécan G; Coste J; Varescon-Pousson I; Christoforov B; Boissonnas A
    Eur J Epidemiol; 2000 May; 16(5):439-45. PubMed ID: 10997831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV risk behaviours among injecting drug users in Northeast India following scale-up of a targeted HIV prevention programme.
    Armstrong G; Humtsoe C; Kermode M
    BMC Public Health; 2011 Dec; 11 Suppl 6(Suppl 6):S9. PubMed ID: 22375900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.
    Sarkar S; Panda S; Sarkar K; Hangzo CZ; Bijaya L; Singh NY; Das N; Agarwal A; Chatterjee A; Deb BC
    Indian J Public Health; 1995; 39(3):86-92. PubMed ID: 8690497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The intersection between sex and drugs: a cross-sectional study among the spouses of injection drug users in Chennai, India.
    Solomon SS; Srikrishnan AK; Celentano DD; Johnson SC; Vasudevan CK; Murugavel KG; Anand S; Kumar MS; Solomon S; Mehta SH
    BMC Public Health; 2011 Jan; 11():39. PubMed ID: 21235816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug use and risk behaviour profile, and the prevalence of HIV, hepatitis C and hepatitis B among people with methamphetamine use in Iran.
    Moradi G; Hajarizadeh B; Rahmani K; Mohamadi-Bolbanabad A; Darvishi S; Zareie B; Zavareh FA; Sharafi H; Alavian SM; Ramazani R; Eftekhar M; Radfar SR; Piroozi B; Gouya MM
    Int J Drug Policy; 2019 Nov; 73():129-134. PubMed ID: 31654935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends in HIV and HCV Risk Behaviors and Prevalent Infection Among People Who Inject Drugs in New York City, 2005-2012.
    Neaigus A; Reilly KH; Jenness SM; Hagan H; Wendel T; Gelpi-Acosta C; Marshall DM
    J Acquir Immune Defic Syndr; 2017 Jul; 75 Suppl 3(Suppl 3):S325-S332. PubMed ID: 28604434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran.
    Rahimi-Movaghar A; Razaghi EM; Sahimi-Izadian E; Amin-Esmaeili M
    Int J Infect Dis; 2010 Jan; 14(1):e28-33. PubMed ID: 19464218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
    Burt RD; Hagan H; Garfein RS; Sabin K; Weinbaum C; Thiede H
    J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.